Compositions for activating pyruvate kinase

Compositions for the activation of PKR are provided, as well as therapeutic administration of the compositions for the treatment of pyruvate kinase-related medical conditions, such as pyruvate kinase deficiency (PKD).

Saved in:
Bibliographic Details
Main Authors Gustafson, Gary, Mitchell, Lorna, Lancia, Jr., David R, Green, Neal, Shelekhin, Tatiana, Zheng, Xiaozhang
Format Patent
LanguageEnglish
Published 17.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compositions for the activation of PKR are provided, as well as therapeutic administration of the compositions for the treatment of pyruvate kinase-related medical conditions, such as pyruvate kinase deficiency (PKD).
Bibliography:Application Number: US201916593523